Highlights Catalyst Biosciences

Equities

CBIO

US14888D2080

Real-time Estimate Cboe BZX Other stock markets 11:34:48 09/05/2024 pm IST			5-day change	1st Jan Change
15.5 ^USD	-1.21%		+13.20%	+100.80%

2023	Catalyst Biosciences, Inc.(NasdaqCM:CBIO) dropped from NASDAQ Composite Index	CI
2023	Beijing Continent Pharmaceutical Co., Ltd. completed the acquisition of Catalyst Biosciences, Inc. in a reverse merger transaction.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Beijing Continent Pharmaceutical Co., Ltd. completed the acquisition of Catalyst Biosciences, Inc. in a reverse merger transaction.	30/23/30	CI
Catalyst Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	27/23/27	CI
Catalyst Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
Catalyst Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16	CI
Catalyst Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31	CI
GC Biopharma Takes Over Catalyst Biosciences' Orphan Hematology Disorder Treatment Candidates	01/23/01	MT
Ex-dividend day	13/23/13	FA
GNI to Take Controlling Stake in Nasdaq-listed Catalyst Biosciences via Liver Fibrosis Drug Development Deals; Shares Up 3%	28/22/28	MT
Catalyst Biosciences Acquires F351, Controlling Interest in Continent From GNI Group	27/22/27	MT
Catalyst Biosciences Inc and GNI Group Ltd Merger Call	27/22/27	FA
GNI Group Ltd. and Catalyst Biosciences, Inc. Sign Agreements to Advance Liver Fibrosis Drug Development	27/22/27	CI
Catalyst Biosciences Completes First Steps in Reverse Merger Plan	27/22/27	AQ
Catalyst Biosciences, Inc. Signed Agreements to acquire 65.2% stake in Catalyst Biosciences, Inc. from GNI Group Ltd. and Shanghai Genomics, Inc. for approximately CNY 3.8 billion.	27/22/27	CI
Catalyst Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
Ex-dividend day	21/22/21	FA
Catalyst Biosciences to Pay Special Cash Dividend of $1.43 a Share on Sept. 20 to Holders as of Sept. 6	25/22/25	MT
Catalyst Biosciences, Inc. Declares Special One-Time Cash Dividend, Payable on September 20, 2022	25/22/25	CI
Catalyst Biosciences Says JDS1 Litigation Dismissed	19/22/19	MT
Catalyst Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
Catalyst Biosciences Gets Favorable Court Ruling in Shareholder JDS1's Motion for Expedited Proceedings Regarding Disclosures	06/22/06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Catalyst Biosciences

Equities

CBIO

US14888D2080

Highlights

Filters